Probing the binding dynamics of a sunitinib analog with human serum albumin: a combined spectroscopic and molecular docking approach

The study of protein binding, particularly interactions involving human serum albumin (HSA), is critical for elucidating drug performance and optimizing therapeutic efficacy.